A 9 panel drug test cup screens a urine specimen for nine drug classes in one device. It is not a federal standard. The only federally fixed configuration is the 5 panel used in regulated transportation testing under 49 CFR Part 40. Everything above that count, including 6, 9, 10, 12 and larger panels, is a custom combination that a lab or employer puts together to match a workplace policy, a clinic's monitoring needs, or a court order. A 9 panel is a common middle ground: broader than the basic federal five, narrower and less expensive than a full 12 panel cup.
What a 9 Panel Drug Test Screens For
Panel letters are standardized abbreviations used across the industry, though the exact mix on any single cup is set by the manufacturer and printed on the package insert. A typical 9 panel configuration includes:
- AMP, amphetamine
- BAR, barbiturates
- BZO, benzodiazepines
- COC, cocaine metabolite
- MET, methamphetamine
- MTD, methadone
- OPI, opiates (morphine, codeine)
- PCP, phencyclidine
- THC, marijuana metabolite
Many suppliers sell variants of the same 9 panel that swap one line for a different analyte depending on what the buyer is trying to catch. The two most common swaps are OXY (oxycodone and related semi-synthetic opioids) in place of a second opiate line, and BUP (buprenorphine) for programs monitoring medication assisted treatment. Before ordering, a buyer should confirm the exact nine analytes on the specific cup, since "9 panel" describes a count, not one fixed list.
Typical Screening Cutoffs and Detection Windows
Screening is an immunoassay test. It reports a preliminary positive when a drug class is present at or above a cutoff concentration, measured in nanograms per milliliter (ng/mL). For the analytes that overlap with the federally regulated panel, that is, THC, cocaine metabolite, opiates, PCP, and amphetamine/methamphetamine, the cutoff concentrations below come directly from the table published by the Department of Transportation at 49 CFR 40.85. For BAR, BZO, and MTD, which are not part of the federal five, cutoffs are set by the test manufacturer and are not uniform across brands, so the figures below are typical values seen on commercial immunoassay inserts rather than a single legal standard.
| Analyte | Typical screening cutoff | Approximate detection window in urine |
|---|---|---|
| AMP, amphetamine | 500 ng/mL (federal confirmatory cutoff 250 ng/mL) | 1 to 3 days |
| BAR, barbiturates | commonly 200 to 300 ng/mL, varies by manufacturer | short acting agents around 1 to 4 days, long acting agents up to several weeks |
| BZO, benzodiazepines | commonly 200 to 300 ng/mL, varies by manufacturer | short acting agents around 1 to 3 days, long acting agents with active metabolites can run several weeks |
| COC, cocaine metabolite (benzoylecgonine) | 150 ng/mL (federal confirmatory cutoff 100 ng/mL) | 2 to 4 days |
| MET, methamphetamine | 500 ng/mL (federal confirmatory cutoff 250 ng/mL) | 2 to 4 days |
| MTD, methadone | commonly 300 ng/mL, varies by manufacturer | can extend well beyond a week with maintenance dosing |
| OPI, opiates (morphine, codeine) | 2000 ng/mL at screening and confirmation | 1 to 3 days |
| PCP, phencyclidine | 25 ng/mL at screening and confirmation | can extend to several days and longer with heavy use |
| THC, marijuana metabolite | 50 ng/mL (federal confirmatory cutoff 15 ng/mL) | a few days after single use, up to several weeks with frequent heavy use |
Detection windows vary widely by dose, frequency of use, individual metabolism, and hydration, so none of these ranges apply exactly to a specific person. The Substance Abuse and Mental Health Services Administration's workplace resources make the same point about federal workplace testing generally: the rules for how a program is run are consistent, but biological response is not, and individual results always route through review rather than a fixed calendar.
Screening Result Versus Confirmed Result
A 9 panel cup, like any immunoassay cup, only produces a preliminary screening result. A line that reads positive at the cutoff is not a confirmed finding of drug use. Federal workplace testing procedure, and the general practice most labs follow for non-federal testing, sends any non-negative screen to a certified laboratory for confirmation by gas chromatography or liquid chromatography with mass spectrometry, which identifies the specific analyte rather than a drug class. A medical review officer (MRO), a licensed physician trained in this review process, then contacts the person tested to ask about current prescriptions before a result is reported to the employer. A prescription for a benzodiazepine, a barbiturate, methadone through a licensed treatment program, or an opioid pain medication is exactly the kind of information the MRO step exists to capture. This is also why a positive screen on a 9 panel cup should never be treated as a final answer by anyone other than the MRO and the certified lab. Point of care devices themselves are generally CLIA waived for use outside a traditional lab setting, which covers how simple the test is to run, not whether a screening result counts as a diagnosis.
Where the 9 Panel Fits Between the 5 Panel and 10 to 12 Panel Cups
The 5 panel federal configuration (AMP, COC, OPI, PCP, THC) is fixed by regulation for DOT regulated safety sensitive positions and cannot be customized by the employer. Everything a non-regulated employer, clinic, or treatment program chooses beyond that is a business decision, not a legal requirement, and SAMHSA's guidance is explicit that non-federal programs vary. A 9 panel adds four analytes commonly tied to prescription misuse and diversion risk, BAR, BZO, MET as a separate line from AMP, and MTD, without going as far as a 10 to 12 panel cup, which typically adds MDMA, methaqualone, propoxyphene, or an expanded opioid line on top of that. For a closer look at what sits above a 9 panel, see our 12 panel drug test breakdown, and for the next tier below full expansion, our 10 panel urine drug screen guide.
Who Chooses a 9 Panel Drug Test Cup
A 9 panel is a common fit for:
- Non-DOT employers in construction, warehousing, manufacturing, and general staffing who want coverage beyond the basic federal five but do not need a full 12 to 14 panel cup.
- Outpatient clinics and addiction treatment programs that need to monitor for benzodiazepine, barbiturate, and methadone use alongside the standard illicit drug classes.
- Probation, drug court, and case management programs where the referring agency specifies a broader analyte list than a basic 5 panel.
Programs weighing the OXY or BUP variant should match the swap to the actual risk they are managing. A clinic running a buprenorphine based medication assisted treatment program generally wants the BUP line to confirm the medication is present and being taken as prescribed, while an employer concerned about prescription opioid diversion may prefer the OXY line. Neither swap adds coverage for drugs the cup was not built to detect. A standard 9 panel will not flag synthetic opioids, novel psychoactive substances, or newer stimulants that are not among its nine analytes, and no rapid panel should be assumed to cover a substance that is not explicitly listed on its insert. When a program needs to know whether a specific analyte is covered, the manufacturer's package insert and the testing laboratory are the sources to check, not an assumption based on the panel count. Full test cup options, including 9, 10, and 12 panel configurations, are available through our drug test cup collection.
Frequently asked questions
Is a 9 panel drug test the same everywhere?
No. There is no federal definition of a 9 panel. The nine analytes vary by manufacturer, so the specific list should always be confirmed on the product insert before ordering or interpreting a result.
Does a 9 panel test for synthetic opioids like fentanyl?
Not unless fentanyl is specifically listed as one of the nine analytes on that cup. A standard 9 panel built around AMP, BAR, BZO, COC, MET, MTD, OPI, PCP, and THC does not include fentanyl. Programs concerned about fentanyl exposure need a cup or strip that lists fentanyl by name.
Can a prescription cause a positive result on a 9 panel?
Yes. Prescribed benzodiazepines, barbiturates, methadone dispensed through a licensed treatment program, and prescription opioids can all produce a non-negative screen. This is reviewed by the medical review officer, who contacts the individual about current prescriptions before any result is reported.
How is a 9 panel different from the DOT 5 panel?
The DOT 5 panel is fixed by federal regulation under 49 CFR Part 40 for safety sensitive transportation employees and covers AMP, COC, OPI, PCP, and THC only. A 9 panel is a non-regulated, employer or clinic chosen configuration that adds BAR, BZO, MET as its own line, and MTD.
What happens after a 9 panel screen comes back non-negative?
A non-negative screening result is a preliminary finding. Standard practice sends the specimen to a certified laboratory for confirmation testing, and a medical review officer reviews the confirmed result with the individual before it is reported as positive.
This article is general information about drug testing panels and is not legal or medical advice. Employers and programs should consult qualified counsel and a medical review officer for decisions about specific policies or results.
